Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-18-051547

Chief Financial Officer bought 26,000 shares at $0.73 ($19,055)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Broadfoot Jill Marie Chief Financial Officer 2018-09-14 Purchase +26,000 $0.73 $19,055 26,000 D
Open-market purchases · 26,000 sh · avg $0.73 · $19,055
Loading xslF345X03/doc4.xml…